Atlas Trials

Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET

Clinical trial NCT01374451 · TERMINATED

Trial details

NCT number
NCT01374451
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Islet Cell Tumor
Start date
2011-06-01
Primary completion
2015-02-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.